VKTX - Latest News
Viking Therapeutics, Inc. (VKTX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $3.24B. Beta to the broader market is 0.65.
The article list below shows the most recent VKTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent VKTX Headlines
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
zacks.com - Oct 14, 2026
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports a
Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity
prnewswire.com - Oct 14, 2026
SUNRISE -1 and SUNRISE-2 Studies to Evaluate Oral VK2735 in Obese Adults with and without Type 2 Diabetes SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- V
3 Absurdly Cheap Stocks to Buy Before the End of 2026
fool.com - Oct 13, 2026
These stocks are priced incredibly low and possess significant upside.
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
zacks.com - Oct 12, 2026
NVO's 11% slide in a month reflects intensifying LLY competition, pricing pressure and a lack of near-term growth visibility despite its long-term pip
Oppenheimer Thinks Viking Therapeutics Stock Can Soar to $120. Here's the Math Behind the Ultra-Bullish Call.
fool.com - Oct 12, 2026
Analyst opinions and sales projections for weight loss and type 2 diabetes drug VK2735 vary widely, reflecting both promise and uncertainty. VK2735's
How News Affects VKTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track VKTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked VKTX news questions
- What is the latest VKTX news headline?
- The most recent VKTX headline (Oct 14, 2026) is "Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the VKTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What VKTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual VKTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.